Media Summary: ... participants uh joining this uh webinar Maybe um we can get started So um I can use the three minutes to introduce uh uh Presentation Title: A Perspective Review of FDA's Draft Guidance on the Use of Presented by Georg Gerber, Assistant Professor of Pathology at the Harvard Medical School and member of the Harvard-MIT ...

Dr Giulia Cereda A Bayesian - Detailed Analysis & Overview

... participants uh joining this uh webinar Maybe um we can get started So um I can use the three minutes to introduce uh uh Presentation Title: A Perspective Review of FDA's Draft Guidance on the Use of Presented by Georg Gerber, Assistant Professor of Pathology at the Harvard Medical School and member of the Harvard-MIT ... Mitchell Miglis, MD, Stanford Health Care, Stanford, CA, discusses the significance of autonomic dysfunction as an early marker of ... By Joanne Soo, MD, Chief Resident Physician. This Grand Round took place on May 4, 2026. 11th Annual Rare Disease Day Event: Advancing Neurodegenerative Disease Research February 25, 2026 Broad Institute ...

Stephanie Kwai Yee Ma Professor, School of Biomedical Sciences Li Ka Shing Faculty of Medicine The University of Hong Kong ...

Photo Gallery

Dr. Giulia Cereda | A Bayesian nonparametric approach for the rare type problem
Reflection on the recent FDA Draft Guidance on the Use of Bayesian Methodology in Clinical Trials
A Perspective Review of FDA's Draft Guidance on the Use of Bayesian Methodology in Clinical Trials
ADA 2020: A Bayesian Narrative of Glycaemic Control on MACE — Dr Shao Hui
Georg Gerber: Bayesian Machine Learning Models for Understanding Microbiome Dynamics | IACS Seminar
Bayesian and Adaptive Trial Designs for Ultra-Rare Populations - NORD Scientific Symposium
Bayesian adaptive trial designs for precision medicine
Persyst Grand Rounds with Dr. Giulia Benedetti (June 27th, 2022)
Developing biomarkers based on early autonomic dysfunction in movement disorders
Circulating Biomarkers: Products, Innovations, and Limitations in Head and Neck Cancers
11th Annual Rare Disease Day Event: Juliana Gentile
Glial Dysregulation and Cognitive Impairment Following Cancer Therapies
View Detailed Profile
Dr. Giulia Cereda | A Bayesian nonparametric approach for the rare type problem

Dr. Giulia Cereda | A Bayesian nonparametric approach for the rare type problem

Speaker:

Reflection on the recent FDA Draft Guidance on the Use of Bayesian Methodology in Clinical Trials

Reflection on the recent FDA Draft Guidance on the Use of Bayesian Methodology in Clinical Trials

... participants uh joining this uh webinar Maybe um we can get started So um I can use the three minutes to introduce uh uh

A Perspective Review of FDA's Draft Guidance on the Use of Bayesian Methodology in Clinical Trials

A Perspective Review of FDA's Draft Guidance on the Use of Bayesian Methodology in Clinical Trials

Presentation Title: A Perspective Review of FDA's Draft Guidance on the Use of

ADA 2020: A Bayesian Narrative of Glycaemic Control on MACE — Dr Shao Hui

ADA 2020: A Bayesian Narrative of Glycaemic Control on MACE — Dr Shao Hui

Dr

Georg Gerber: Bayesian Machine Learning Models for Understanding Microbiome Dynamics | IACS Seminar

Georg Gerber: Bayesian Machine Learning Models for Understanding Microbiome Dynamics | IACS Seminar

Presented by Georg Gerber, Assistant Professor of Pathology at the Harvard Medical School and member of the Harvard-MIT ...

Bayesian and Adaptive Trial Designs for Ultra-Rare Populations - NORD Scientific Symposium

Bayesian and Adaptive Trial Designs for Ultra-Rare Populations - NORD Scientific Symposium

Bayesian

Bayesian adaptive trial designs for precision medicine

Bayesian adaptive trial designs for precision medicine

Dr

Persyst Grand Rounds with Dr. Giulia Benedetti (June 27th, 2022)

Persyst Grand Rounds with Dr. Giulia Benedetti (June 27th, 2022)

Dr

Developing biomarkers based on early autonomic dysfunction in movement disorders

Developing biomarkers based on early autonomic dysfunction in movement disorders

Mitchell Miglis, MD, Stanford Health Care, Stanford, CA, discusses the significance of autonomic dysfunction as an early marker of ...

Circulating Biomarkers: Products, Innovations, and Limitations in Head and Neck Cancers

Circulating Biomarkers: Products, Innovations, and Limitations in Head and Neck Cancers

By Joanne Soo, MD, Chief Resident Physician. This Grand Round took place on May 4, 2026.

11th Annual Rare Disease Day Event: Juliana Gentile

11th Annual Rare Disease Day Event: Juliana Gentile

11th Annual Rare Disease Day Event: Advancing Neurodegenerative Disease Research February 25, 2026 Broad Institute ...

Glial Dysregulation and Cognitive Impairment Following Cancer Therapies

Glial Dysregulation and Cognitive Impairment Following Cancer Therapies

by Michelle Monje, MD, PhD.

YW2023: "...Phenotypic Plasticity in HCC to Mitigate Therapy Resistance & Tumor Recurrence" - Dr. Ma

YW2023: "...Phenotypic Plasticity in HCC to Mitigate Therapy Resistance & Tumor Recurrence" - Dr. Ma

Stephanie Kwai Yee Ma Professor, School of Biomedical Sciences Li Ka Shing Faculty of Medicine The University of Hong Kong ...